2006Zhongguo xin yao zazhiRequires access

Recent progresses of the proton pump inhibitors benzimidazoles

Bo‐Jun Yuan

Open publisher page 0 citations

Abstract

This review detailed the pharmacological mechanism, pharmacokinetics, clinical applications and safety profiles of the proton pump inhibitors, including omeprazole, lansoprazole, panto-prazole, rabeprazole, leminoprazole and perprazole.

About this research paper

What this paper is about

This review detailed the pharmacological mechanism, pharmacokinetics, clinical applications and safety profiles of the proton pump inhibitors, including omeprazole, lansoprazole, panto-prazole, rabeprazole, leminoprazole and perprazole.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This review detailed the pharmacological mechanism, pharmacokinetics, clinical applications and safety profiles of the proton pump inhibitors, including omeprazole, lansoprazole, panto-prazole, rabeprazole, leminoprazole and perprazole.

Key concepts: Chemistry, Pharmacology, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Recent progresses of the proton pump inhibitors benzimidazoles — Research Paper | ScholarLens